BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 9402107)

  • 1. Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.
    Blom DJ; Goslings WR; De Waard-Siebinga I; Luyten GP; Claas FH; Gorter A; Jager MJ
    J Interferon Cytokine Res; 1997 Nov; 17(11):695-700. PubMed ID: 9402107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.
    Varsano S; Rashkovsky L; Shapiro H; Radnay J
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):522-9. PubMed ID: 9730881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-mediated modulation of integrin, ICAM-1 and CD44 expression on human uveal melanoma cells in vitro.
    Creyghton WM; de Waard-Siebinga I; Danen EH; Luyten GP; van Muijen GN; Jager MJ
    Melanoma Res; 1995 Aug; 5(4):235-42. PubMed ID: 7496158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
    Gollob JA; Sciambi CJ
    Clin Cancer Res; 2007 Sep; 13(17):5219-25. PubMed ID: 17785578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
    Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
    Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.
    Wu Y; Wang Y; Qin F; Wang Z; Wang Y; Yang Y; Zheng H; Wang Y
    Am J Physiol Gastrointest Liver Physiol; 2014 Jun; 306(12):G1056-64. PubMed ID: 24763553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 12 cytokines in aqueous humour of uveal melanoma before and after combined Ruthenium-106 brachytherapy and transpupillary thermotherapy.
    Lee CS; Jun IH; Kim TI; Byeon SH; Koh HJ; Lee SC
    Acta Ophthalmol; 2012 Jun; 90(4):e314-20. PubMed ID: 22429778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between c-myc expression and interferon sensitivity in uveal melanoma.
    Tulley PN; Neale M; Jackson D; Chana JS; Grover R; Cree I; Grobbelaar AO; Wilson GD
    Br J Ophthalmol; 2004 Dec; 88(12):1563-7. PubMed ID: 15548813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
    Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
    Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human hepatocytes are protected against complement by multiple regulators.
    Halme J; Sachse M; Vogel H; Giese T; Klar E; Kirschfink M
    Mol Immunol; 2009 Jul; 46(11-12):2284-9. PubMed ID: 19446335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.